“Gretchen LeFever Watson: The Deadly Dangers of ADHD Drugs”
Gretchen LeFever Watson, a clinical psychologist, connects the US opioid crisis to the overdiagnosis of ADHD in a guest editorial for The Virginian Pilot....
Study 329 Taper Phase
Most doctors still affect surprise at the idea SSRIs might come with withdrawal problems. Regulators knew very clearly since 2002 about the problems, but have decided to leave any communication of these issues in company hands.
Use of Antidepressants Linked to Diabetes
Selective serotonin reuptake inhibitors (such as Prozac and Zoloft) are the most commonly prescribed medication for depression. SSRIs have long been associated with an...
Clinical Trials Underreport Harms of Antidepressant Medications
A group of researchers recently found serious bias in the reporting of harm due to adverse events in antidepressant medication clinical trials. They report...
Hormonal Contraception May Increase Risk for Depression and Antidepressant Treatment
The results of the nationwide study, analyzing data from over one million women, suggest that hormonal contraceptive use may increase the risk of depression and use of antidepressants, especially for adolescents.
iPad Use Before Surgery as Effective as Sedatives for Children
A group of French doctors presented a new study in the area of pediatric anesthesiology at this year’s World Congress of Anaesthesiologists in Hong...
New Study Casts Doubt on Efficacy of Ketamine for Depression
A new study, published this month in the Journal of Affective Disorders, investigated the effectiveness of weekly intravenous ketamine injections as a treatment for...
Study 329 Continuation Phase
All the fuss about Study 329 centers on its 8-week acute phase. But this study had a 24-week Continuation Phase that has never been published. Until Now.
How Do Antidepressants Really ‘Work’?
A recent review, published in Neuroscience & Biobehavioral Reviews, challenges the dominant assumptions about the neurochemical and therapeutic effects of Selective Serotonin Reuptake Inhibitors...
Antidepressant Effects Thwarted by Stressful Environments
A new study, about to be published in the journal Brain, Behavior, and Immunity, investigates the role a stressful environment plays in antidepressant effectiveness....
German Psychologists Declare “the Drugs Don’t Work”
Jürgen Margraf and Silvia Schneider, both well-known psychologists at the University of Bochum in Germany, claim that psychotropic drugs are no solution to mental...
STOP or GO? Tapering Pregnant Women off of Antidepressants
A team in the Netherlands is currently investigating the effects of tapering off of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) during pregnancy....
Ghostwriting has a New Name but Same Problems
A new paper, published in the British Medical Journal, explains how the pharmaceutical industry has publicly denounced ghostwriting while still finding ways to engage...
CDC Advises Nonopioid Treatments for Chronic Pain
Primary care clinicians and mental health providers face a particular set of challenges when treating individuals with chronic pain. These problems are compounded by...
The ADHD Drug Epidemic: Addiction, Abuse, and Death
A new analysis of FDA data, published on September 10th by the Milwaukee Journal Sentinel/MedPage Today, reveals the dangers of the common prescription of...
Psychiatric Drug Ads Lead to More Prescriptions and Worse Treatment
A new analysis published in the The Journal of Clinical Psychiatry investigates the public health effects of direct-to-consumer advertisements for psychiatric drugs. The researchers...
“FDA Panel Votes to Remove Serious Warning from Pfizer’s Smoking Cessation Pill”
This week an FDA advisory panel decided to remove warnings of serious psychiatric side effects from the Chantix product label. “In making its recommendation,...
Enough is Enough Series, #5 – The ADHD Fiction is Exposed. The French Have...
The time has come that the fictitious ADHD qualifies for my ‘Enough is Enough’ series. It’s time to stop addressing pharmaceutical psychiatry on its own terms: its fraudulent and corrupt 'science,' its spurious 'evidence base,' and its imaginary psychiatric ‘diseases.’ I’m done with this. The evidence is in. Let’s get real. Psychiatry has become a profession of drug pushers. As a psychiatrist I am beyond troubled. Let’s get real.
“FDA questions Pfizer Study of Chantix Psychiatric Effects”
Pfizer is petitioning the FDA to remove the black box warning for Chantix which focuses on neuropsychiatric side-effects like suicidality and depression. The regulators...
“Overprescribing of Drugs for Adult ADHD Causing ‘Trail of Misuse, Addiction and Death'”
An investigative report finds that the over-prescription of ADHD drugs is causing “a trail of misuse, addiction, and death.” “At morgues in Florida, a...
Review Calls for Critical look at Prescribing Antidepressant Drugs
The August issue of Psychotherapy and Psychosomatics published a review conducted by André F. Carvalho and colleagues regarding the literature around the long-term use...
Meta-Analysis Finds Exercise Improves Cognition in Individuals with Schizophrenia
A new review, published in Schizophrenia Bulletin, examines the effects of exercise on cognition in individuals diagnosed with 'schizophrenia.' The results of the meta-analysis...
Confessions of a Trespasser
In a recently published commentary in Psychiatric Times, Ronald Pies and Joseph Pierre made this assertion: Only clinicians, with an expertise in assessing the research literature, should be weighing in on the topic of the efficacy of psychiatric drugs. They wrote their commentary shortly after I had published on madinamerica “The Case Against Antipsychotics,” and it was clear they had me in their crosshairs.
Petition Calls on Pharma Companies to Offer Tapering Kits for Depression and Anxiety Drugs
A change.org petition out of the United Kingdom is addressing the extreme difficulty faced by people who attempt to taper off of antidepressants and...
“The DEA Is Placing Kratom and Mitragynine On Schedule I”
The US Drug Enforcement Agency (DEA) is moving to place Kratom, a southeast Asian plant often used in teas, on the schedule 1 banned...
